Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.21 | N/A | +25185.13% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.21 | N/A | +25185.13% |
| Revenue | N/A | N/A | N/A |
Tone: Confident
Management expressed confidence in the company's financial performance, particularly highlighting the unexpected EPS results. They emphasized their commitment to pipeline development.
We are pleased with our strong EPS performance this quarter.
Our focus remains on advancing our pipeline and strategic partnerships.
Ionis Pharmaceuticals reported a significant earnings surprise with an EPS of $2.21, leading to a strong stock reaction of up 15.12%. The lack of revenue data means investors will be looking for more information in future reports. The positive EPS result indicates strong operational performance, which could bolster investor confidence moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Terex Corporation